ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
67,363.68
0.63%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. MacroGenics Inc (MGNX)

  7. MacroGenics Inc (MGNX) Noticias

MGNX

MacroGenics (MGNX)

MacroGenics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:MGNX
FechaHoraFuenteTítuloSímboloCompañía
13/05/202406:30GlobeNewswire Inc.MacroGenics to Participate in Upcoming Investor ConferencesNASDAQ:MGNXMacroGenics Inc
09/05/202415:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGNXMacroGenics Inc
09/05/202415:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MGNXMacroGenics Inc
09/05/202415:01GlobeNewswire Inc.MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim TAMARACK Phase 2 Study DataNASDAQ:MGNXMacroGenics Inc
03/05/202406:30GlobeNewswire Inc.MacroGenics Announces Date of First Quarter 2024 Financial Results Conference CallNASDAQ:MGNXMacroGenics Inc
03/04/202415:30GlobeNewswire Inc.MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future DisclosuresNASDAQ:MGNXMacroGenics Inc
08/03/202415:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGNXMacroGenics Inc
07/03/202415:01GlobeNewswire Inc.MacroGenics Provides Update on Corporate Progress and 2023 Financial ResultsNASDAQ:MGNXMacroGenics Inc
06/03/202415:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MGNXMacroGenics Inc
27/02/202416:45GlobeNewswire Inc.MacroGenics Announces Date of Fourth Quarter 2023 Financial Results Conference CallNASDAQ:MGNXMacroGenics Inc
14/02/202416:01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MGNXMacroGenics Inc
14/02/202409:04Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:MGNXMacroGenics Inc
02/02/202415:30GlobeNewswire Inc.MacroGenics to Participate in Upcoming Investor ConferenceNASDAQ:MGNXMacroGenics Inc
15/11/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MGNXMacroGenics Inc
06/11/202315:09Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MGNXMacroGenics Inc
06/11/202315:01GlobeNewswire Inc.MacroGenics Provides Update on Corporate Progress and Third Quarter 2023 Financial ResultsNASDAQ:MGNXMacroGenics Inc
31/10/202315:30GlobeNewswire Inc.MacroGenics Announces Date of Third Quarter 2023 Financial Results Conference CallNASDAQ:MGNXMacroGenics Inc
05/09/202306:00GlobeNewswire Inc.MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research ProgramNASDAQ:MGNXMacroGenics Inc
09/08/202315:01GlobeNewswire Inc.MacroGenics Provides Update on Corporate Progress and Second Quarter 2023 Financial ResultsNASDAQ:MGNXMacroGenics Inc
31/07/202316:35GlobeNewswire Inc.MacroGenics Announces Date of Second Quarter 2023 Financial Results Conference CallNASDAQ:MGNXMacroGenics Inc
02/06/202315:59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MGNXMacroGenics Inc
02/06/202307:40Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MGNXMacroGenics Inc
09/05/202315:01GlobeNewswire Inc.MacroGenics Provides Update on Corporate Progress and First Quarter 2023 Financial ResultsNASDAQ:MGNXMacroGenics Inc
04/05/202315:30GlobeNewswire Inc.MacroGenics Announces Date of First Quarter 2023 Financial Results Conference CallNASDAQ:MGNXMacroGenics Inc
28/04/202305:23Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:MGNXMacroGenics Inc
19/04/202315:06Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:MGNXMacroGenics Inc
17/04/202315:26Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:MGNXMacroGenics Inc
22/03/202313:19Dow Jones NewsIncyte Gets FDA Approval of Zynyz, Triggers Milestone Payment to MacroGenicsNASDAQ:MGNXMacroGenics Inc
22/03/202312:22GlobeNewswire Inc.MacroGenics Earns $15 Million Milestone Following U.S. FDA Approval of ZYNYZ™ (retifanlimab-dlwr)NASDAQ:MGNXMacroGenics Inc
15/03/202316:21Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:MGNXMacroGenics Inc
 Showing the most relevant articles for your search:NASDAQ:MGNX

Su Consulta Reciente

COIN
EXPOGBP
USOTC
SDTTU
SandRidge Mississippian ... (CE)
NASDAQ
LSMFX
Lord Abbett Sustainable ...
NASDAQ
FUQQUX
Cboe Vest Enhanced Large...
BIT
F16153
Vontobel Financial Produ...
AQSE
CXAD.GB
UBS
EU
ALDAF
ALD Domestic bond Frn 6o...
NYSE
CXP
Columbia Property
TSX
5139
OpenWork
EU
XS0405267062
Bng Usd 5 23 38
BOV
BRSR5M
BANRISUL PNA
NYSE
PACS
PACS
COIN
XMYUST
Myriad
BMF
DIIN24U24
DIIN24U24 - 07/2024
BIT
F18301
Vontobel Financial Produ...
LBNK
GKIUSDT
GKi
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados